Prognosis
J&J Covid-19 Vaccine Trial Cleared to Start in South Africa
- Regulator approved the local arm of the trial on Thursday
- J&J has signed agreement to have vaccine made in South Africa
This article is for subscribers only.
Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter
Johnson & Johnson will imminently start clinical trials of its Covid-19 vaccine in South Africa after getting regulatory approval, according to the co-chair of the study in the country.